Patients with lymphopenia might merit lymphocyte-sparing strategies—such as avoiding unnecessary corticosteroids or using radiotherapy plans that minimize lymphocyte dose—and could benefit from adjunctive measures including nutritional support or exploratory IL-7–based interventions [32, 33]. This evidence concerns the gene IL7 and lymphopenia.